Elevance Health Inc. ($ELV) Stock Forecast: Down 8.4% Today

What is Elevance Health Inc.?

Elevance Health (ELV) in the healthcare sector saw significant bearish activity in the market today.

Why is Elevance Health Inc. going down?

ELV stock is down 8.4% on Jul 18, 2025 16:46

• ELV's Q2 earnings fell short of expectations because of escalating medical expenses, mainly from Medicaid and ACA costs.
• Although there was a 14.3% rise in Q2 revenue compared to the previous year, the company reduced its projected FY25 EPS, pointing to increased ACA and Medicaid expenses as the main factors.
• Analysts issued downgrades on Elevance Health, which added to the pessimistic outlook on the stock.
• Concerns about surging costs and declining Medicaid enrollments affecting ELV's profitability in the second quarter led to a negative market response.

ELV Price Chart

ELV Technical Analysis

ELV News

Company News for Jul 18, 2025

Companies in The News Are: ...

https://www.zacks.com/stock/news/2591758/company-news-for-jul-18-2025

This Elevance Health Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday - Clearside Biomedical ( NASDAQ:CLSD ) , Elevance Health ( NYSE:ELV )

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Leerink Partners analyst Whit Mayo downgraded Elevance Health, Inc.

https://www.benzinga.com/analyst-stock-ratings/downgrades/25/07/46489421/this-elevance-health-analyst-is-no-longer-bullish-here-are-top-4-downgrades-for-

Elevance Health Q2 Earnings Miss Estimates on Rising Medical Costs

ELV's Q2 EPS slides 12.6% y/y and misses estimates as rising Medicaid and ACA costs weigh on the results.

https://www.zacks.com/stock/news/2589242/elevance-health-q2-earnings-miss-estimates-on-rising-medical-costs

Why Elevance Health Stock Is Tumbling Thursday - Elevance Health ( NYSE:ELV )

Q2 revenue rose 14.3% Y/Y to $49.42 billion, topping the $48.34 billion consensus. FY25 EPS guidance cut to ~$30, below consensus of $34.40, citing higher ACA and Medicaid costs. A new wave of value and momentum stocks could be setting up for major moves-and Tim Melvin will name them live this ...

https://www.benzinga.com/markets/earnings/25/07/46468951/elevance-health-hit-by-medicaid-troubles-trims-outlook

Elevance to Report Q2 Earnings: Will Rising Costs Pressure Profits?

ELV's second-quarter earnings may face pressure as rising costs and lower Medicaid memberships offset strong revenue gains.

https://www.zacks.com/stock/news/2580044/elevance-to-report-q2-earnings-will-rising-costs-pressure-profits

Trending Today

Roblox Corp ($RBLX) Stock Forecast: Up 3.1% Today

Essex Property Trust Inc. ($ESS) Stock Forecast: Down 4.0% Today

Astera Labs Inc ($ALAB) Stock Forecast: Up 6.1% Today

Verisk Analytics Inc. ($VRSK) Stock Forecast: Down 2.8% Today

Mondelez International Inc. ($MDLZ) Stock Forecast: Down 5.7% Today

Booking Holdings Inc. ($BKNG) Stock Forecast: Down 0.8% Today

Groupon Inc. ($GRPN) Stock Forecast: Down 5.0% Today

Bausch + Lomb ($BLCO) Stock Forecast: Down 6.3% Today

PPG Industries Inc. ($PPG) Stock Forecast: Down 5.1% Today

SolarEdge Technologies, Inc. ($SEDG) Stock Forecast: Down 5.1% Today

Elevance Health Inc. Price History

17.06.2025 - ELV Stock was down 10.5%

• ELV's Q2 revenue rose by 14.3% year-over-year, exceeding projections. However, the company reduced its FY25 EPS guidance due to increased ACA and Medicaid expenses.
• Anticipated cost escalations and decreased Medicaid enrollments are likely to impact ELV's Q2 earnings.
• Investor apprehension may stem from doubts about the company's capability to efficiently control expenses and sustain profitability in the face of tough market conditions.

17.06.2025 - ELV Stock was down 8.6%

• ELV experienced a strong bearish movement today as investors may be concerned about the company's upcoming Q2 earnings.
• Rising costs and lower Medicaid memberships are expected to pressure ELV's profits, leading to a negative market sentiment.
• The anticipation of a decline in ELV's Q2 earnings, coupled with the lack of key ingredients for a potential earnings beat, could have contributed to the bearish market movement.
• Investors are advised to closely monitor ELV's earnings and key metrics to gain a better understanding of the company's performance and future outlook.

17.06.2025 - ELV Stock was down 12.9%

• ELV's Q2 earnings fell short of expectations due to escalating medical expenses, particularly related to Medicaid and ACA.
• Despite a 14.3% increase in Q2 revenue compared to the previous year, the company adjusted its FY25 EPS forecast downwards, sparking worries among investors.
• The market responded unfavorably to the announcement of potential profit challenges arising from higher costs and decreased Medicaid enrollments.
• The convergence of earnings missing estimates, guidance revision, and apprehensions about cost pressures contributed to a significant drop in ELV's stock price today.

15.04.2025 - ELV Stock was down 6.1%

• The announcement of a class action lawsuit may have spooked investors, leading to a sell-off of ELV shares.
• Despite historically outperforming the market with an annualized return of 13.94%, concerns surrounding the legal proceedings seem to have overshadowed its long-term performance.
• Investors might be reacting to the uncertainty and potential financial implications of the lawsuit, causing a significant decline in ELV's stock price today.

23.04.2025 - ELV Stock was down 5.3%

• The bearish movement in ELV's stock today can be attributed to the class action lawsuits filed against the company on behalf of its stockholders for potential violations of federal securities laws. This legal uncertainty has likely caused investor concern and led to a sell-off of ELV shares.
• The negative impact on health care stocks like ELV could have been further exacerbated by the broader market trend, as indicated by the decline in other health care companies such as UnitedHealth and CVS following CMS's announcement of audits on MA contracts.
• Investors with substantial losses in ELV are being given the opportunity to lead class action lawsuits, adding to the legal pressures faced by the company and contributing to the downward pressure on its stock price.
• The upcoming class action deadline for ELV shareholders to contact law firms further highlights the legal challenges surrounding the company, potentially leading to continued volatility in its stock performance.

16.04.2025 - ELV Stock was up 7.7%

• Despite bearish options activity, the stock of Elevance Health (ELV) experienced a bullish movement today.
• The announcement of a class action lawsuit may have initially caused some uncertainty among investors, but it seems that the market sentiment quickly turned positive.
• The long-term outperformance of Elevance Health likely contributed to investor confidence and drove the bullish movement in the stock today.
• Overall, the positive market movement of ELV could be attributed to the company's strong historical performance and resilience in the face of legal challenges.

02.06.2025 - ELV Stock was down 8.3%

• The upcoming court deadline for the lawsuit against Elevance Health, Inc. may have caused uncertainty and negative sentiment among investors.
• The legal issues and potential violations by the company's senior executives could be contributing to the bearish movement in ELV stock.
• Investors might be reacting to the news by selling off their positions in ELV, leading to the strong bearish movement in the stock today.

18.06.2025 - ELV Stock was down 6.1%

• ELV stock experienced a strong bearish movement today due to a series of negative news and analyst actions.
• The company's Q2 earnings missed estimates, with EPS sliding and facing pressure from rising medical costs, particularly from Medicaid and ACA expenses.
• Despite a 14.3% Y/Y increase in Q2 revenue, ELV's FY25 EPS guidance was cut below consensus, citing higher costs.
• Analyst downgrades and concerns about rising costs and lower Medicaid memberships contributed to the bearish market movement of ELV today.

18.06.2025 - ELV Stock was down 8.4%

• ELV's Q2 earnings fell short of expectations because of escalating medical expenses, mainly from Medicaid and ACA costs.
• Although there was a 14.3% rise in Q2 revenue compared to the previous year, the company reduced its projected FY25 EPS, pointing to increased ACA and Medicaid expenses as the main factors.
• Analysts issued downgrades on Elevance Health, which added to the pessimistic outlook on the stock.
• Concerns about surging costs and declining Medicaid enrollments affecting ELV's profitability in the second quarter led to a negative market response.

22.04.2025 - ELV Stock was down 5.4%

• ELV stock plummeted due to the announcement of a class action lawsuit indicating potential violations by the company and its executives, leading to investor uncertainty and selling pressure.
• The broader health care sector, including companies like UnitedHealth and CVS, also faced a downturn following regulatory actions, adding to the negative sentiment in the industry.
• Investors with substantial losses in ELV are being urged to participate in the class action lawsuit, further exacerbating the negative outlook for the company and contributing to the bearish market movement.
• The legal challenges and uncertainties surrounding Elevance Health have overshadowed its historical market outperformance, causing a sharp decline in its stock price today.

08.03.2025 - ELV Stock was up 5.2%

• The strong bullish movement in ELV's stock could be attributed to the surge in trading volume observed in the last session, indicating increased investor interest.
• Despite a notable increase, further upside may be limited in the near term due to trends in earnings estimate revisions.
• Positive reactions from investors to recent developments or news related to Elevance Health may have contributed to the stock price increase despite potential limitations on future price increases.
• Monitoring new information or updates regarding ELV is crucial for making informed decisions about investment strategies.

17.03.2025 - ELV Stock was down 6.6%

• The bearish movement in ELV stock today could be attributed to investors' concerns about the implied volatility surging in the stock options market.
• The anticipation of the upcoming earnings report might have led to profit-taking by some traders, causing a downward pressure on the stock price.
• The increased attention on ELV stock options could indicate a higher level of uncertainty or speculative trading, contributing to the bearish trend in the market today.